相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape
A. Modelska et al.
CELL DEATH & DISEASE (2015)
A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma
E. Horvilleur et al.
LEUKEMIA (2014)
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
Andrew L. Wolfe et al.
NATURE (2014)
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
Lise Boussemart et al.
NATURE (2014)
Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity
Kateryna Feoktistova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A
R. Cencic et al.
BLOOD CANCER JOURNAL (2013)
The biological and therapeutic relevance of mRNA translation in cancer
Sarah P. Blagden et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation
Brigitte Lankat-Buttgereit et al.
BIOLOGY OF THE CELL (2009)
The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo
David M. Lucas et al.
BLOOD (2009)
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Nahum Sonenberg et al.
CELL (2009)
Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
Regina Cencic et al.
PLOS ONE (2009)
Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A
ME Bordeleau et al.
NATURE CHEMICAL BIOLOGY (2006)
eIF-4E expression and its role in malignancies and metastases
A De Benedetti et al.
ONCOGENE (2004)
分享论文
